Literature DB >> 12161597

Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome.

D Monk, L Bentley, C Beechey, M Hitchins, J Peters, M A Preece, P Stanier, G E Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12161597      PMCID： PMC1735212          DOI： 10.1136/jmg.39.8.575

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  19 in total

1.  Genome-wide methylation analysis of retrocopy-associated CpG islands and their genomic environment.

Authors:  Katrin Grothaus; Deniz Kanber; Alexandra Gellhaus; Barbara Mikat; Julia Kolarova; Reiner Siebert; Dagmar Wieczorek; Bernhard Horsthemke
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

2.  IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis.

Authors:  Marc-Oliver Riener; Josef Hoegel; Heinrich Iro; Arndt Hartmann; Abbas Agaimy
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

3.  Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis.

Authors:  Tao Wu; Xuan Zhang; Lu Xing; Dingguo Pan; Ping Liu; Rong Ding; Renfang Yang; Xudong Yang; Yunfeng Li
Journal:  Dis Markers       Date:  2022-05-30       Impact factor: 3.464

4.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.

Authors:  David F Schaeffer; Daniel R Owen; Howard J Lim; Andrew K Buczkowski; Stephen W Chung; Charles H Scudamore; David G Huntsman; Sylvia S W Ng; David A Owen
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

5.  Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese cases.

Authors:  Xiangjie Sun; Ping Wei; Chen Shen; Yusi Yang; Yiqin Wang; Yuan Li; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

6.  IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.

Authors:  Peng Su; Jing Hu; Hui Zhang; Weiwei Li; Ming Jia; Xiaofang Zhang; Xiaojuan Wu; Hongxia Cheng; Lei Xiang; Gengyin Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Authors:  Zhong Jiang; Christine M Lohse; Peigou G Chu; Chin-Lee Wu; Bruce A Woda; Kenneth L Rock; Eugene D Kwon
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

8.  Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation.

Authors:  Kristen E Govoni; Seong Keun Lee; Robert B Chadwick; Hongrun Yu; Yuji Kasukawa; David J Baylink; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-02-07       Impact factor: 4.310

9.  Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.

Authors:  Kristian Ikenberg; Florian R Fritzsche; Ursina Zuerrer-Haerdi; Irina Hofmann; Thomas Hermanns; Helge Seifert; Michael Müntener; Maurizio Provenzano; Tullio Sulser; Silvia Behnke; Josefine Gerhardt; Ashkan Mortezavi; Peter Wild; Ferdinand Hofstädter; Maximilian Burger; Holger Moch; Glen Kristiansen
Journal:  BMC Cancer       Date:  2010-06-30       Impact factor: 4.430

10.  Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis.

Authors:  Steffen Blenk; Julia C Engelmann; Stefan Pinkert; Markus Weniger; Jörg Schultz; Andreas Rosenwald; Hans K Müller-Hermelink; Tobias Müller; Thomas Dandekar
Journal:  BMC Cancer       Date:  2008-04-16       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.